Business Wire
12 Dec 2025, 03:24 UTC · 47w ago
Contineum Therapeutics Announces Pricing of Upsized $90.0 Million Public Offering
Verdict
Headline takes no side. We score CTNM +0.30 — moderately bullish.
- Expected · CTNM
+0.30moderately bullish
−1 bearish0bullish +1More positive than 60% of ticker scores this week
- Actual





